ScholarIQanswers from OpenAlex
University of Verona
InstitutionResearch output, impact & collaborations
University of Verona is a institution indexed in ScholarIQ from OpenAlex.
What is known about University of Verona?
ScholarIQrecord summary
University of Verona is a research organisation in Verona, IT. OpenAlex records 64,075 works and 5,258,169 citations for it. 10,280 researchers list it as their most recent affiliation.
How many works does University of Verona have?
ScholarIQindexed works
University of Verona has 64,075 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does University of Verona have?
ScholarIQcitation count
University of Verona has 5,258,169 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at University of Verona?
ScholarIQresearcher count
University of Verona has 10,280 researchers in the ScholarIQ index.
What is the average h-index at University of Verona?
ScholarIQavg h-index
University of Verona has an average h-index of 61.3 in OpenAlex.
What is the ROR of University of Verona?
ScholarIQror
The ROR for University of Verona is on the source record.
What is the OpenAlex record for University of Verona?
ScholarIQopenalex
The OpenAlex for University of Verona is on the source record.
What is the Wikidata of University of Verona?
ScholarIQwikidata
The Wikidata for University of Verona is on the source record.
Who are the most-cited researchers behind University of Verona?
ScholarIQtop researchers by citations
What are the most-cited papers on University of Verona?
ScholarIQmost cited works
Sarcopenia: revised European consensus on definition and diagnosis
Alfonso J. Cruz‐Jentoft, Gülistan Bahat, Jürgen M. Bauer, Yves Boirie, Olivier Bruyère, Tommy Cederholm, Cyrus Cooper, Francesco Landi, Yves Rolland, Avan Aihie Sayer, S. Schneider, Cornel Sieber, Eva Topinková, M. Vandewoude, Marjolein Visser, Mauro Zamboni, Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2, Ivan Bautmans, Jean‐Pierre Baeyens, Matteo Cesari, Antonio Cherubini, John А. Kanis, Marcello Maggio, Finbarr C. Martin, Jean‐Pierre Michel, Kaisu Pitkälä, Jean‐Yves Reginster, René Rizzoli, Dolores Sánchez‐Rodríguez, Jos M. G. A. Schols
Sarcopenia: European consensus on definition and diagnosis
Alfonso J. Cruz‐Jentoft, Jean‐Pierre Baeyens, Jürgen M. Bauer, Yves Boirie, Tommy Cederholm, Francesco Landi, Finbarr C. Martin, Jean‐Pierre Michel, Yves Rolland, S. Schneider, Eva Topinková, M. Vandewoude, Mauro Zamboni
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
Evelina Tacconelli, Elena Carrara, Alessia Savoldi, Stephan Harbarth, Marc Mendelson, Dominique L. Monnet, Céline Pulcini, Gunnar Kahlmeter, Jan Kluytmans, Yehuda Carmeli, Marc Ouellette, Kevin Outterson, Jean B. Patel, Marco Cavaleri, Edward Cox, Chris R Houchens, M. Lindsay Grayson, Paul Hansen, Nalini Singh, Ursula Theuretzbacher, Nicola Magrini, Aaron O. Aboderin, Seif Al-Abri, Nordiah Awang Jalil, Nur Benzonana, Sanjay Bhattacharya, Adrian Brink, Francesco Burkert, Otto Cars, Giuseppe Cornaglia, Oliver J. Dyar, Alex W. Friedrich, Ana Cristina Gales, Sumanth Gandra, Christian G. Giske, Debra A. Goff, Herman Goossens, Thomas Gottlieb, Manuel Guzmán Blanco, Waleria Hryniewicz, Deepthi Kattula, Timothy Jinks, Souha S. Kanj, Lawrence D. Kerr, Marie-Paule Kiény, Yang Soo Kim, Roman S. Kozlov, Jaime Labarca, Ramanan Laxminarayan, Karin Leder, Leonard Leibovici, Gabriel Levy-Hara, Jasper Littman, Surbhi Malhotra‐Kumar, Vikas Manchanda, Lorenzo Moja, B Ndoye, Angelo Pan, David L. Paterson, Mical Paul, Haibo Qiu, Pilar Ramón-Pardo, Jesús Rodríguez‐Baño, Maurizio Sanguinetti, Sharmila Sengupta, Mike Sharland, Massinissa Si-Mehand, Lynn L. Silver, Wonkeung Song, Martin Steinbakk, Jens Thomsen, Guy Thwaites, J W van der Meer, Nguyễn Văn Kính, Silvio Vega, María Virginia Villegas, Agnes Wechsler-Fördös, Heiman Wertheim, Evelyn Wesangula, Neil Woodford, Fidan O Yilmaz, Anna Zorzet
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
Rafael Rosell, Enric Carcereny, Radj Gervais, A. Vergnenègre, Bartomeu Massutí, Enriqueta Felip, Ramón Palmero, Ramón García-Gómez, Cinta Pallarés, José Miguel Sánchez, Rut Porta, Manuel Cobo, Pilar Garrido, Flavia Longo, Teresa Morán, Amelia Insa, Filippo de Marinis, R. Corre, Isabel Bover, Alfonso Illiano, Éric Dansin, Javier de Castro, Michèle Milella, Noemı́ Reguart, Giuseppe Altavilla, Ulpiano Jiménez, Mariano Provencio, Miguel Ángel Moreno, Josefa Terrasa, José Muñoz-Langa, Javier Valdivia, Dolores Isla, Manuel Dómine, Olivier Molinier, Julien Mazières, Nathalie Baize, Rosario García‐Campelo, G. Robinet, Delvys Rodríguez‐Abreu, Guillermo López-Vivanco, Vittorio Gebbia, Lioba Ferrera-Delgado, P. Bombaron, Reyes Bernabé, Alessandra Bearz, Á. Artal, Enrico Cortesi, Christian Rolfo, María Sanchez-Ronco, Ana Drozdowskyj, Cristina Queralt, Itziar de Aguirre, José Luis Ramírez, José Javier Sánchez, Miguel Ángel Molina‐Vila, Miquel Tarón, Luis Paz‐Ares
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
Mohammed Eslam, Philip N. Newsome, Shiv Kumar Sarin, Quentin M. Anstee, Giovanni Targher, Manuel Romero‐Gómez, Shira Zelber‐Sagi, Vincent Wai‐Sun Wong, Jean‐François Dufour, Jörn M. Schattenberg, Takumi Kawaguchi, Marco Arrese, Luca Valenti, Gamal Shiha, Claudio Tiribelli, Hannele Yki‐Järvinen, Jian-Gao Fan, Henning Grønbæk, Yusuf Yılmaz, Helena Cortez‐Pinto, Cláudia P. Oliveira, Pierre Bédossa, Leon A. Adams, Ming‐Hua Zheng, Yasser Fouad, Wah‐Kheong Chan, Nahúm Méndez‐Sánchez, Sang Hoon Ahn, Laurent Castéra, Elisabetta Bugianesi, Vlad Ratziu, Jacob George
How much of the research on University of Verona is open access?
ScholarIQopen access share
83%OPEN ACCESS